- Home
- GOODO vs MRK Comparison
GOODO vs MRK Comparison
Compare GOODO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOODO
- MRK
- Stock Information
- Founded
- GOODO N/A
- MRK 2000
- Country
- GOODO United States
- MRK United States
- Employees
- GOODO 72
- MRK N/A
- Industry
- GOODO Real Estate
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- GOODO Real Estate
- MRK Health Care
- Exchange
- GOODO Nasdaq
- MRK Nasdaq
- Market Cap
- GOODO N/A
- MRK 218.8B
- IPO Year
- GOODO N/A
- MRK N/A
- Fundamental
- Price
- GOODO $20.22
- MRK $84.61
- Analyst Decision
- GOODO
- MRK Buy
- Analyst Count
- GOODO 0
- MRK 15
- Target Price
- GOODO N/A
- MRK $105.14
- AVG Volume (30 Days)
- GOODO N/A
- MRK 13.0M
- Earning Date
- GOODO N/A
- MRK 10-30-2025
- Dividend Yield
- GOODO N/A
- MRK 3.82%
- EPS Growth
- GOODO N/A
- MRK 20.41
- EPS
- GOODO N/A
- MRK 6.49
- Revenue
- GOODO N/A
- MRK $63,616,000,000.00
- Revenue This Year
- GOODO N/A
- MRK $1.84
- Revenue Next Year
- GOODO N/A
- MRK $5.24
- P/E Ratio
- GOODO N/A
- MRK $13.07
- Revenue Growth
- GOODO N/A
- MRK 1.82
- 52 Week Low
- GOODO N/A
- MRK $73.31
- 52 Week High
- GOODO N/A
- MRK $110.19
- Technical
- Relative Strength Index (RSI)
- GOODO 48.69
- MRK 50.44
- Support Level
- GOODO $20.15
- MRK $86.20
- Resistance Level
- GOODO $20.25
- MRK $85.50
- Average True Range (ATR)
- GOODO 0.18
- MRK 2.34
- MACD
- GOODO 0.01
- MRK -0.25
- Stochastic Oscillator
- GOODO 58.17
- MRK 49.31
About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).